Literature DB >> 11750964

A randomised trial of progesterone prophylaxis after midtrimester amniocentesis.

Francesco Corrado1, Corrado Dugo, Maria L Cannata, Massimo Di Bartolo, Angela Scilipoti, Narcisio Carlo Stella.   

Abstract

BACKGROUND: Midtrimester amniocentesis to investigate fetal karyotype carries a small risk of fetal loss. AIM: To test the hypothesis that progesterone prophylaxis may reduce this. STUDY
DESIGN: A randomised controlled trial comparing a short prophylactic treatment with progesterone after amniocentesis with untreated controls.
RESULTS: There were no differences in frequency of miscarriage, preterm delivery or neonatal outcome.
CONCLUSION: Prophylactic progesterone treatment after amniocentesis does not improve obstetric outcome.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11750964     DOI： 10.1016/s0301-2115(01)00418-3

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


  8 in total

Review 1.  Amniocentesis and chorionic villus sampling for prenatal diagnosis.

Authors:  Zarko Alfirevic; Kate Navaratnam; Faris Mujezinovic
Journal:  Cochrane Database Syst Rev       Date:  2017-09-04

Review 2.  Amniocentesis and chorionic villus sampling for prenatal diagnosis.

Authors:  Z Alfirevic; K Sundberg; S Brigham
Journal:  Cochrane Database Syst Rev       Date:  2003

3.  A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition.

Authors:  Jennifer C Condon; Pancharatnam Jeyasuria; Julie M Faust; James W Wilson; Carole R Mendelson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

4.  Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.

Authors:  David M Haas; Taylor J Hathaway; Patrick S Ramsey
Journal:  Cochrane Database Syst Rev       Date:  2019-11-20

5.  Progestogens for preventing miscarriage: a network meta-analysis.

Authors:  Adam J Devall; Argyro Papadopoulou; Marcelina Podesek; David M Haas; Malcolm J Price; Arri Coomarasamy; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

6.  Use of progestagens during early pregnancy.

Authors:  G Dante; V Vaccaro; F Facchinetti
Journal:  Facts Views Vis Obgyn       Date:  2013

7.  Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.

Authors:  David M Haas; Taylor J Hathaway; Patrick S Ramsey
Journal:  Cochrane Database Syst Rev       Date:  2018-10-08

8.  Progestogen for treating threatened miscarriage.

Authors:  Hayfaa A Wahabi; Amel A Fayed; Samia A Esmaeil; Khawater Hassan Bahkali
Journal:  Cochrane Database Syst Rev       Date:  2018-08-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.